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ABSTRACT
The three Golgi fractions isolated from rat liver homogenates by the procedure given
in the companion paper account for 6-7 % of the protein of the total microsomal fraction
used as starting preparation . The lightest, most homogeneous Golgi fraction (GFI) lacks
typical "microsomal" activities, e.g., glucose-6-phosphatase, NADPH-cytochrome c-reduc-
tase, and cytochrome P-450. The heaviest, most heterogeneous fraction (GF3) is con-
taminated by endoplasmic reticulum membranes to the extent of -15% of its protein.
The three fractions taken together account for nearly all the UDP-galactose :N-acetyl-
glucosamine galactosyltransferase of the parent microsomal fraction, and for -70% of
the activity of the original homogenate . Omission of the ethanol treatment of the animals
reduces the recovery by half. The transferase activity is associated with the membranes of
the Golgi elements, not with their content . Galactose is transferred not only to N-acetyl-
glucosamine but also to an unidentified lipid-soluble component .
INTRODUCTION'
In the preceding paper (2), we have described the
isolation of a series of three Golgi fractions from
rat liver homogenates . The procedure relies on the
overloading of Golgi elements with very low
density lipoprotein (VLDL) 2 particles which pro-
vide an enclosed morphological marker and
change the density of Golgi-derived vesicles
enough to allow their separation from vesicles
derived from the endoplasmic reticulum . The
' A partial, preliminary report of these findings was
presented at the 10th Annual Meeting of the Amer-
ican Society for Cell Biology (1).
2 Abbreviations used in this paper : AcPase, Acid phos-
phatase ; AMPase, 5'-nucleotidase ; cyt., cytochrome;
ER, endoplasmic reticulum; G6Pase, glucose-6-phos-
phatase, PLP, phospholipid ; VLDL, very low density
lipoprotein.
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overloading is produced in vivo by ethanol
treatment.
In this paper we present the data obtained so
far on the chemistry and enzymology of these
fractions.
MATERIALS AND METHODS
General
The preparation of the animals, the fractionation
of liver homogenates, the isolation of Golgi fractions,
and their subfractionation into membranes and con-
tent have been described in reference 2 .
COMMON OOLOI FRACTION : For the prepara-
tion of a common Golgi fraction, the total microsome
pellet was resuspended in 0 .25 M sucrose and the con-
centration of sucrose was subsequently brought up to
1.3 M (by adding 2.0 M sucrose). 20-m1 aliquots of
73this suspension were used as bottom load under a
20-ml layer of 1.15 M sucrose and a 20-m1 layer of
0.25 M sucrose. Upon centrifugation in a SW 25.2
rotor for 3.5 h at 25,000 rpm (75,500 gay,), a heavy
band formed at the 0.25 M/1.15 M sucrose interface .
This band is expected to represent the sum of GFI,
GF2, and GF 3 .
SUB FRACTIONATION OF MICROSOMES : For
the purpose of comparison, an aliquot of the total
microsomal fraction was subfractionated into mem-
branes and content by using the procedure worked
out for Golgi fractions ; i.e., the microsomes were
suspended in hypotonic (0.04 M) veronal buffer, pH
8.5, passed twice through a French press, brought up
to 0.25 M sucrose, and centrifuged for 60 min at
105,000 g8v . The resulting pellet and supernate
were called "microsomal membranes" and "micro-
somal contents," respectively (see Fig. 17 in refer-
ence 2). Presumably the treatment released much of
the contents of the microsomal vesicles, just as it did
in the case of the Golgi fractions . The situation was
not investigated in greater detail, however, so that the
use of the term "membranes" and "contents" is
largely arbitrary; it implies only that these fractions
have been treated in the same way as the Golgi frac-
tions.
PREPARATION OF MITOCHONDRIA AND LY-
SOSOMAL FRACTIONS : For certain comparative
enzymological assays, mitochondrial, lysosomal, and
Golgi fractions were isolated from a common ho-
mogenate. Aliquots of the latter were spun for 15 min
at 485 gav in an International centrifuge, model
SBV (International Scientific Instruments Inc.,
Palo Alto, Calif.), to remove unbroken cells, cell
debris, and nuclei, and the resulting supernate was
recentrifuged for 15 min at 3,300 gay . The second
supernate was carefully drawn off with a pipette and
saved to isolate the lysosomal fraction. The pellet was
gently resuspended in 0 .25 M sucrose and the sus-
pension spun for 10 min at 3,300 g&v . The cycle was
repeated once and the final pellet, resuspended in
water or buffer, is referred to as the "total mito-
chondrial fraction ."
The supernate from the first 3,300 g spin was
recentrifuged for 20 min at 12,500 g .v . The ensuing
supernate was discarded, the pellet resuspended
(after rinsing its surface) in 0.30 M sucrose, and the
suspension spun for 10 min at 9,500 ggv . The cycle
was repeated once and the final pellet, resuspended
in 0.30 M sucrose, is referred to as the "total lyso-
somal fraction." This procedure is a modification of
that of Sawant et al. (3).
Gross Chemistry
PROTEIN : Protein was assayed by the method of
Lowry et al. (4) with bovine plasma albumin as a
standard.
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PHOSPHOLIPID : Lipids were extracted by the
method of Folch-Pi et al . and washed with 0.73%
NaCl (5). Inorganic phosphate was determined (6)
in the ashed, acid-hydrolyzed extracts and phospho-
lipid amounts were estimated by multiplying lipid
P by 25.
RNA : Fraction aliquots were precipitated and
washed several times with cold 10% TCA . The pre-
cipitates were then extracted for 20 min with hot
(90°C) 5% TCA, and RNA in the extract was
determined by the orcinol method (7).
Enzyme Assays
All phosphatases were determined by previously
published methods, with minor modifications as
indicated below. Glucose-6-phosphatase (G6Pase)
was assayed by the method of Swanson (8) using 30
mM Tris-maleate buffer (pH 6.6), 5 MM MgC12i
and 4 mM glucose-6-phosphate ; 5'-nucleotidase
(AMPase) by the method of Heppel and Hilmoe (9)
using 28 mM Tris-HCl buffer (pH 8.5), 3 mM
MgC12, and 3.5 mM adenosine-5'-phosphate ; or
that of Widnell and Unkeless (10) using 83 mM
Tris-HCI (pH 8.5), 17 MM MgC12, and 17 mM
adenosine-5'-phosph ate ; and acid phosphatase
(AcPase) by the method of Wattiaux and de Duve
(11) . Inorganic phosphate was determined in all
cases by the procedure of Ames and Dubin (6).
NADH- and NADPH-cytochrome (cyt.) c-reduc-
tase were assayed as described by Ernster et al . (12)
and Dallner et al. (13) (without rotenone in the
NADH-cyt. c-reductase assay) ; cytochrome oxidase
was determined by the procedure of Cooperstein and
Lazarow (14) ; and cyt. b5 and cyt. P-450 were
measured as done by Dallner et al. (13).
UDP-galactose: N-acetylglucosamine galactosyl-
transferase activity was determined in two different
ways. In the first procedure (Babad and Hassid [15]
as modified by Fleischer et al. [16]), the assay mixture
contained 0.3 M sodium cacodylate (pH 6.5), 10 µl ;
0.3 M MnC12 , 10 µl ; 0.3 M $-mercaptoethanol, 10
µl; 15 mM uridine diphospho-[ 14C]galactose, 2.43 X
105 dpm/µmol, 10 p1 ;3 0.3 M N-acetylglucosamine,
10 µl ; and about 50-75 µg protein equivalent of the
cell fraction to be assayed in 10 µl. After a 20-min
incubation at 37 °C, the reaction was stopped by
plunging the tubes in ice and adding 20 µl of 0.3 M
EDTA (pH 7.4). The mixture was passed through a
0.5 X 2.0-cm column of Dowex 2X8 (200-400
mesh ; Dow Chemical Co., Midland, Mich.) in the
Cl- form, and the column was eluted with 3 X 0 .5-
3 UDP-[14C]galactose (200 mCi/mmol) was evapo-
rated to dryness (to remove ethanol) and then
resuspended in a solution of UDP-[12C]galactose at
the concentration and specific radioactivity indi-
cated.ml samples of distilled H20 directly into scintillation
vials containing Bray's solution . The samples were
counted on a Beckman liquid scintillation spectrom-
eter (Beckman Instruments Inc., Spinco Div., Palo
Alto, Calif.). The blank contained all the ingredients
of the assay except N-acetylglucosamine . The differ-
ence in radioactivity between experimental samples
and blank is taken to represent the amount of galac-
tose transferred to N-acetylglucosamine during the
reaction.
The second procedure, based on the chromato-
graphic separation of the reaction product, N-
acetyllactosamine, was carried out basically as de-
scribed by Fleischer et al. (16). At the end of the
reaction as carried out above, the assay mixture was
applied as a bar 0.5-cm long at the origin on DEAE
paper (Whatman no. DE81). The developing solvent
was n-butanol : n-propanol : water (3 : 1 :1, vol/vol/vol)
and chromatography was continued for 48-72 h . The
paper was dried and cut into 0.5 X 2-cm strips which
were extracted in 0.5 ml of water and counted in
Bray's solution. Standards (100-200 µg) were run
and visualized by the method of Travelyan et al .
(17) as modified by J . Gregory (personal communi-
cation) using sodium hyposulfide ("hypo") to reduce
the background of the stain. In some cases, lipid
soluble radioactive compounds (see Results) were
removed from the assay mixture before paper chro-
matography. The extraction procedure was carried
out by adding an equal volume (80 µl) of chloroform:
methanol (2 vol: l vol) to the assay mixture . After
shaking, the mixture distributed into an upper
aqueous phase (-107 µl) and a lower organic phase
('53 µl). An aliquot (50 µl) of the upper phase was
removed with a Hamilton syringe (Hamilton Co .,
Reno, Nev.) and chromatographed as described
above.
Sources of Materials
The reagents used were obtained from the follow-
ing sources : glucose-6-phosphate (disodium salt), cyt.
c (type III, from horse heart), and NADPH from
Sigma Chemical Company, St . Louis, Mo. ; AMP
(yeast) and NADH from Mann Research Labora-
tories, Inc., New York, and UDP-[ 14C]galactose
from New England Nuclear, Boston, Mass .
RESULTS
Protein Recovery in Golgi Fractions
In the case of ethanol-treated animals, we re-
covered 6-7 % of the protein of the parental micro-
somal fraction or 1 .5-1 .8% of that of the original
liver homogenate in our set of three Golgi frac-
tions or in our common Golgi fraction (Table IV) .
Since approximately one-third of the Golgi ele-
ments of the entire cell population of the liver was
probably lost in the first steps of our procedure
before the isolation of microsomes (see below), we
can estimate that only - .2-3 % of the total protein
of the liver is associated with Golgi complexes .
The estimate is commensurate with the small
relative volume of this cell organ in hepatocytes
and agrees well with recently published stereo-
logical data (18) which assess at -3% the frac-
tional volume of the Golgi complex in the hepato-
cytes of the adult rat.
In agreement with the differences recorded in
centrifugal band patterns (2), -40% less protein
was recovered in Golgi fractions prepared without
previous ethanol treatment of the animals (Table
V) .
Characterization of GF, and GF, Membranes
GENERAL CHEMISTRY : GF, accounts for
only 0.36% of the protein of the parental micro-
somal fraction (Table I) and probably represents
no more than -3 % of all the Golgi elements pres-
ent in the original homogenate . It is, however, the
most homogeneous of our Golgi fractions; more-
over it contains the whole spectrum of Golgi
elements present in a hepatocyte although in a
definitely different mix than that found in situ (2) .
On account of its homogeneity and assuming that
it is relatively representative, we have used GF,
in an attempt to characterize in some detail Golgi
elements and Golgi membranes . Data on protein,
phospholipid, and RNA content of the whole
fraction and of its membranes and contents, pre-
pared as described in (2), are given in Table I.
The high phospholipid : protein ratio of GF,
(0.50) is due to the VLDLs it contains: upon their
removal, the ratio in GF, membranes (0.36) be-
comes comparable to that found in microsomal
membranes after corrcction for ribosomal proteins
(0.35).
GF, and GF, membranes gave very low, vari-
able, and questionable4 values when assayed for
4 Orcinol reacts with carbohydrates under the con-
ditions of the RNA assay to give a product which
absorbs at ,665 nm (absorption maximum of RNA,
reference 19) as well as at 565 nm. OD565 can be used
as a test for contamination of RNA by sugars (20).
The ratio OD665/OD565 is four for purified RNA,
and 3 and -0.4 for hot TCA extracts of micro-
somes and GFI, respectively. The figures in Table I
represent maximal values since they were calculated
directly from OD665 ignoring the highly probable
contamination by carbohydrates.
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75TABLE I
Protein, PLP, and RNA Content of Microsomal and Light Golgi Fractions (GF1)
Fractions
	
Protein, pg/g liver*
	
PLP, pg/mg protein
	
RNA, pg/mg protein
The figures are averages of results obtained in four different experiments. Ranges for GF, total and
GFI membranes are given in parentheses.
* Wet weight
$ In these experiments the recovery of microsomes was lower than usual (l5 mg protein/g wet weight
liver) on account of the strong centrifugal field (10,000 gar) applied to remove nuclei and mitochondria .
In subsequent experiments (Tables III-VII) the field was less strong (8,800ga,.) and the recoveries corre-
spondingly higher (20-25 mg).
§ Values in parentheses are corrected for ribosomal proteins .
RNA. It is possible that the corresponding spectro-
photometric readings reflect the presence of
glycoprotein sugars rather than that of RNA ;
hence, it is likely that GF, contains very little, if
any, RNA.
ENZYMATIC ACTIVITIES : GF, was assayed
for a number of enzymes to check the degree of its
homogeneity and to find out whether it has a
characteristic set of activities . The figures given in
Table II for a series of "marker" microsomal 5
enzymes such as G6Pase, NADPH-cyt . c-reduc-
tase, and cyt. P-450 represent the smallest concen-
5 The term microsomes (and, hence, microsomal
marker enzymes) is used here in its operational sense :
it refers to small particles isolated by differential
centrifugation from postmitochondrial supernates as
given under Materials and Methods in reference 2.
The major components of the hepatic microsomal
fraction are vesicles derived from the rough and
smooth ER, both of which contribute the marker
enzymes. In the past ER-derived vesicles have been
equated to microsomes minimizing or ignoring the
presence of minor components in the same fraction,
i.e., Golgi-derived vesicles, plasmalemmal frag-
ments, and other intact or fragmented subcellular
components. The separation of Golgi fractions from
total microsomal fractions leaves behind a large,
residual, but still heterogeneous particle preparation
whose components may appear as contaminants in
the Golgi fractions. These contaminants will be
referred to as ER vesicles when this intracellular
origin can be ascertained or as contaminating re-
sidual microsomes when their derivation is un-
certain.
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trations that could have been detected in GF,
and its membranes given the sensitivity of the
procedures and the amounts of protein used .
Since the assays were negative, it follows that
these enzymes are either absent from GF, and its
membranes or present in concentrations lower
than indicated by the tabulated figures . In view of
the differences known to exist in the sensitivity of
the corresponding assays, the conclusion is firmer
for G6Pase and the NADPH-cyt. c-reductase than
for cyt. P-450. These findings strongly suggest that
the enzymes mentioned are absent from GF,
membranes. In this respect, they are in good
agreement with the lack of cytochemically de-
tectable G6Pase activity in the Golgi elements of
hepatocytes in situ (21-23), and they also agree
with the observation that the induction of the cyt .
P-450 system by barbiturates or other drugs is
accompanied by a marked proliferation of the
endoplasmic reticulum (ER) (24, 25) without a
comparable response from the Golgi complex
(unpublished observations) .
The figures given in the literature (16, 26, 27)
for the specific activities of these microsomal
marker enzymes in Golgi fractions are higher than
ours and most probably reflect the degree of con-
tamination of these fractions by ER-derived
vesicles. In our case, ER contamination, if pres-
ent, should amount to less than 40 J o of the protein
of the GF, assuming, of course, that the latter has
neither the cyt. P-450 system nor G6Pase .
GF, and GF, membranes appear to have, how-
ever, the enzymes of the second microsomal
Microsomal Total$ 15,000 260 (300) § 150
Membranes 10,700 300 (350)§ 135
Content 2,900 75 99
GFI Total 55 (25-80) 500 (430-560) <15 (7-30)
Membranes 19 (7-25) 360 (310-410) <9 (6-40)
Content 31 600 <26TABLE II
Specific Enzymic Activities* of GFI and Other Cell Fractions
33 .00¶
electron transport chain, i.e., NADH-cyt. c-
reductase and cyt. b5. This system which is prob-
ably involved in fatty acid desaturation (28) has a
rather wide distribution among subcellular com-
ponents since it has been detected in microsomes
(29) as well as in the outer mitochondrial mem-
brane (30) and in plasmalemmal fractions (31) .
The reductase is highly labile (12) and this prob-
ably explains the wide variations recorded in our
data. 6 The cytochrome is stable; hence, its specific
activity figures can be considered reliable . These
figures indicate that the enzyme is present in GF,
in a concentration similar to that found in the
plasmalemmal fraction (31) and eight times
lower than that recorded in microsomes . Cyt. b 5
is partially solubilized by our procedure for the
extraction of VLDLs : of the original
amount appears in the extracted content while the
rest remains associated with the membranes of
6 Specific activities fot GF1 range from 0.009 to
0.063 generally in parallel with variations in the
activity of the total microsomal fraction .
* Specific activity units : G6Pase and AMPase, µmol Pi/20 min/mg protein; NADPH and NADH-cyt.
c-reductases, µmol NADPH (NADH) oxidized/min/mg protein ; cyt. P-450, OD450 - OD4 /mg protein ;
cyt. b5, OD424 - OD410/mg protein.
In all experiments, the results were checked for self-consistency by assaying (a) the microsomal fraction
remaining after the isolation of GF1 , (b) the GF1 content fraction. The recoveries were generally high
(>90%) ; cytochromes and enzyme activities were highly concentrated in the membrane fraction except
for cyt. b5 and AMPase of which 26% and 49%, respectively, were recovered in the GFI content fraction.
t Specific activity figures for all microsomal enzyme activities are comparable to those found in the
literature, except for G6Pase and NADH-cyt . c-reductase (lower in our data). Cyt. b5 concentration is
higher than in the literature .
§ Number of experiments.
~~ Widnell-Unkeless (10).
¶ Recalculated from Leighton et al . (44).
the corresponding fractions (e.g., GF, or micro-
somes).
The cyt. b5 chain appears to be indigenous to
GF, membranes. Its presence cannot be explained
by contamination with either residual microsomes
or mitochondria. Such contamination can be
ruled out on both morphological and enzymo-
logical grounds : the fraction is free of"structurally
recognizable mitochondrial and ER contaminants,
and its specific activities for NADH-cyt . c-reduc-
tase and cyt. b5 are considerably higher than those
it shows for well established markers of both
ER (G6Pase, NADPH-cyt. c-reductase) and
mitochondrial (cytochrome oxidase, see below)
membranes.
GF, and its membranes have AMPase activity
at -'u the concentration detected in microsomes
and at a considerably lower concentration (-/ 19)
than found in plasmalemmal fractions. This
activity also appears to be indigenous to GFI
7 The finding is in agreement with Dallner's observa-
tions (32) concerning the ease of extraction of cyt .
b5 from microsomal fractions.
BERGERON, EHRENREICH, SIEKEVITZ, AND PALADE Golgi Fractions II . Biochemistry
	
77
Microsomes GFt
Enzyme activities Totalt
Mem-
branes Total
Plasma-
Membranes lemma
Mito-
chondria
Lyos-
somes
G6Pase (3) § 1 .69 3 .53 <0 .07 <0 .13
NADPH-cyt. c-reductase (4) 0.021 0 .026 <0 .001 <0 .005
Cyt. P-450 (3) 0.031 0.051 <0.005 <0 .010
NADH-cyt. c-reductase (4) 0.15 0.19 0.029 0.025
Cyt. b5 (3) 0.197 0.099 0.026 0.017
AMPase (4) 2 .15 2 .23 1 .59 1 .93
	
9.211 -
Cyt. oxidase (5) 0.08 0.17 0.025 0 .095
	
- 5 .45 -
AcPase (3) 0.66 - 1 .06 -
	
- - 6.90membranes, since morphological findings defi-
nitely rule out contamination of the magnitude
required to ascribe it to contaminant ER or
plasmalemmal fragments . AMPase has often been
considered a plasma membrane marker on account
of the high specific activity it reaches in plasma-
lemmal fractions (31, 10, 33-35), the large pro-
portion of activity generally recovered in micro-
somal fractions (36, 37) being ascribed to con-
tamination by plasmalemmal fragments. This
view was supported by histochemical observations
made on fixed liver tissue which revealed activity
in the plasmalemma but not in the ER (38-40) .
Recently, however, Widnell (41) showed that
AMPase activity can be demonstrated histo-
chemically in unfixed microsomal fractions and
found that the ER enzyme is much more sensitive
to fixation than the plasmalemmal counterpart
thus providing a reasonable explanation for the
results obtained in fixed liver. The same situation
may apply to the Golgi-associated AMPase since
Goldfischer et al. (21) have noted that the complex
gives a negative reaction in situ. Recent cyto-
chemical tests on isolated Golgi fractions show, in
fact, that there is AMPase activity in morpho-
logically identifiable Golgi elements (42) .
GF, and GF, membranes have very little cyto-
chrome oxidase activity. Their specific activity
amounts to only -0.5% of the specific activity of
the mitochondrial fractions we have isolated for
comparison from the same liver homogenates.
This figure should be taken, however, as a maxi-
mal value for mitochondrial contamination, since
mitochondrial fractions with considerably higher
(' four times) specific activities have been pre-
pared by more refined procedures (30, 43). This
low specific activity is in good agreement with the
virtual absence of structurally recognizable mito-
chondrial contaminants in GF, and GF, membrane
pellets.
Finally, the data in Table II show that GF, has
acid phosphatase activity at a concentration
-30 times lower than in liver lysosomes (cf.
3, 44) . The activity could be ascribed to the con-
tamination of the fraction by lysosomes (2) but,
since morphologically recognizable lysosomes do
not account for more than -1 % of the mass of
GFI, the possibility of a mixed distribution of the
enzyme in Golgi elements as well as in lysosomes
remains open. Evidence obtained on granulocytes
(45-47), monocytes (48), and macrophages (49)
shows that in these cells in which the production
of lysosomal enzyme is a major activity, the en-
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zymes in question have a mixed distribution ; they
appear to be routed through Golgi elements on
their way to primary (45-48) or secondary (48,
49) lysosomes. The same may generally apply for
all cell types in which only secondary lysosomes
can be detected (50).
Taken together, the biochemical data in
Table II indicate that GF, is practically free of
ER and mitochondrial contaminants and only
slightly contaminated by lysosomes, although part
of the lysosomal activity detected could be indig-
enous to Golgi elements. Recent cytochemical
tests carried out on isolated Golgi fractions show
that this is indeed the case (42) . Accordingly, the
biochemical data are in good agreement with the
morphological findings already presented (2)
which show that mitochondria are absent from
GF, and the lysosomes present only in small num-
bers; the data are also compatible with the ab-
sence of ER contaminants . The same morpho-
logical observations (2) indicate that contamina-
tion by plasmalemmal fragments must be very
limited, if at all present. Since the fraction is
morphologically homogeneous or nearly homo-
geneous, the biochemical data must describe the
properties of the Golgi elements and Golgi mem-
branes in GF,. They indicate that the makeup of
these membranes is in some respects qualitatively
(absence of G6Pase and cyt. P-450 system) and in
others quantitatively (low concentrations of the
cyt. b 5, NADH-cyt. c-reductase, and AMPase)
different from both ER membranes and plasma-
lemma. The differences are in fact more extensive
as will be shown by the results obtained in assaying
the galactosyltransferase activity of these various
membranes.
Partial Characterization of GF2 and GF3
ENZYMATIC ACTIVITIES : To
	
find
	
out
whether the properties detected for GF, apply also
to heavier Golgi elements, the inquiry was ex-
tended to GF2 and GF3. GF, and microsomal frac-
tions derived from the same homogenates were
included to facilitate comparison, but the assays
were limited to whole fractions and to fewer en-
zymes than in the preceding section . According to
the results obtained (Table III), the activity of
ER marker enzymes remains low in all Golgi
fractions, although there is a marked increase in
specific activity from GF, to GF 3 for both G6Pase
and NADPH-cyt. c-reductase, we assume that this
reflects an increase in contamination by ER-TABLE III
Specific Enzymic Activities of GF1 , GF2 , GF3 , and Other Cell Fractions
* From Benedetti and Emmelot (88). Specific activity units for : G6Pase and AMPase, µmol Pi liberated/
mg protein/20 min ; the reductases, µmol NADPH (NADH) oxidized/mg protein/min ; cyt. b5, AOD
(424 - 410 nm)/mg protein .
derived vesicles which reaches 15-20% in GF3
according to the specific activity figures for G6Pase
and NADPH-cyt. c-reductase, respectively . There
is less change from one Golgi fraction to another
in NADH-cyt. c-reductase and cyt. b 5 concentra-
tion, but there is a relatively large increase in
AMPase specific activity. Since the morphology
of GF2 and GF3 rules out extensive contamination
by plasmalemmal fragments, this increase probably
reflects an actual higher concentration of enzyme
activity in heavier Golgi elements. According to
the data in Table III, all Golgi fractions appear to
be distinct from both plasmalemmal and micro-
somal fractions. In addition, and in agreement
with the morphological findings already described
(2), GFI is more similar to GF, than to GF 3 .
UDP-GA LACTOSE :N-ACETYLGLUCOSAMINE
GALACTOSYLTRANSFERASE: Recent work by
Fleischer et al. (16, 51) and Morre et al . (52) has
shown that Golgi-rich fractions isolated from either
beef (16) or rat (51, 53) liver are highly active in
transferring galactose from UDP-galactose to ex-
ogenous N-acetylglucosamine and has suggested
(16) that this galactosyltransferase is a "marker"
enzyme for Golgi membranes. In their experi-
ments, a considerable increase in transferase ac-
tivity was detected in Golgi-rich fractions over that
found in homogenates and microsomes, but rela-
tively low recoveries were recorded (^-10% in beef
liver and -40% in rat liver), most of the activity
separating with the microsomes.
Since in the case of ethanol-treated animals we
can isolate relatively clean Golgi fractions (GF, and
GF2) and since we recover in our complete set of
Golgi fractions more protein than in some of the
references mentioned, we assayed these fractions
for galactosyltransferase activity by the procedure
of Hassid and Babad (15, 16) in which UDP-[14C]-
galactose is separated by ion exchange chroma-
tography from its transfer and hydrolysis products
and in which it is assumed that the amount of
radioactivity above the blank represents galactose
transferred to N-acetyllactosamine . The results of a
representative experiment (Table IV), out of a
series of six, show that 3. of the transferase activity
of the homogenate remains in a combined "nu-
clear-mitochondrial" fraction, while 23 separate
with the microsomes. Practically 100 c/o of the latter
is recovered in our set of three Golgi fractions,
with a slight overrecovery in our combined Golgi
fraction, and with no detectable activity left in the
residual microsomal fraction . The specific activi-
ties of the various Golgi fractions range from -55
to 100 times higher than that of the original ho-
mogenate. In the absence of previous ethanol
treatment (Table V), the recovery amounts to
only 40-50% of the activity of the initial micro-
somal fraction, in agreement with the difference
in centrifugal band pattern discussed in reference
2. The specific activities are also lower : namely,
only 13-55 times higher than that of the original
homogenate. In both cases, the specific activity of
the combined Golgi fraction is slightly higher than
that of the most active Golgi subfraction, presum-
ably because the introduction of an additional
sucrose layer in the density gradient leads to a
slight degree of purification.
For work on liver cell fractions, the Hassid-
Babad procedure has the disadvantage of giving
high blanks for certain preparations which, in
addition to transferase activity, apparently have
high galactosidase (54) and nucleotide pyrophos-
phatase (55) activities. This is especially the case
for the original homogenates and total microsomal
fractions used as starting preparations for the iso-
lation of our Golgi fractions. On account of the
high blanks mentioned, the reliability of our data
on total activity at the start and on recovery in the
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Enzyme GF1 GF, GE, Micr. fr. Plasma. fr.
G6Pase 0.05 0.10 0.40 2.60
NADPH-cyt. c-reductase 0 .003 0 .004 0.005 0.023
NADH-cyt. c-reductase 0.04 0.09 0.04 0.28
Cyt. b5 0.03 0 .03 0.05 0.07
AMPase 1 .5 2 .5 5.5 2 .50 10.0*TABLE IV
UDP- Galactose: N-Acetylglucosam ine Galactosyltransferase Activity in Cell Fractions Isolated from the Liver of
Ethanol- Treated Rats
The assay procedure used was Babad and Hassid (15), column chromatography.
* Wet weight.
$ nmol galactose transferred/h/mg protein .
§ Refers to microsomal fraction before the removal of Golgi fractions by flotation .
~~ Refers to microsomal fraction left after the removal of GF1 , GF2 , and GF3 .
¶ nd, not detectable.
TABLE V
UDP-Galactose: N-Acetylglucosamine Galactosyltransferase Activity in Cell Fractions Isolated from the Liver of
Control Rats (No Ethanol Treatment)
Assay procedure used was Babad and Hassid (15), column chromatography.
* Wet weight.
$ nmol galactose transferred/h/mg protein.
end can be questioned. To obviate this disad-
vantage and to check on the results already ob-
tained, we used the procedure of Fleischer et al .
(16) which relies on the isolation of the product of
the transfer reaction (N-acetyllactosamine) from
the assay mixture by paper chromatography . In
this procedure, UDP-[14C]galactose remains at the
origin and N-[14C]acetyllactosamine is readily
separated from [14C]galactose. However, when
liver cell fractions are assayed a third unidenti-
fied radioactivity peak is detected running im-
mediately ahead of N-acetyllactosamine (Fig . 1 a
and b).
With the new procedure, we first tried to obtain
maximal transferase activity by adding a detergent
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(Triton X-100, final concentration 0.67 0) to the
assay mixture as done by Schachter et al. (56) . In
the case of GF3 (Fig. 1 a and b), the addition of de-
tergent resulted in a nearly twofold increase in the
amount of radioactivity which appeared in N-
acetyllactosamine without visibility affecting the
transfer of label to the unidentified peak (arrows).
The activity in homogenates and total micro-
somal fractions was low and remained low (two
to three times the background) even in the pres-
ence of the detergent. Moreover, a relatively large
amount of radioactivity was transferred to the
intermediary peak between N-acetyllactosamine
and galactose (Fig . 2 a and b).
Attempts to increase the amount of galactose
Fraction
mg protein
Specific activity] Total activity Recovery % g liver*
Homogenate 180 2 .2 396 .0 100 .0
Microsomal fr. (initial) 25 10.0 250 .0 63 .1
GF1 0.015 30.0 0.45 -
GF2 0.095 110.0 10.45 2 .6
GF3 0.91 100.0 91 .0 23 .0
GF combined 1 .05 120 .0 126 .0 31 .8
Fraction
mg protein
Specific activityl Total activity Recovery % g liver*
Homogenate 195 .00 1 .7 331 100.0
Nuclear-mitochondrial fraction 97 .00 1 .1 107 32 .0
Microsomal fr. (initial) § 26 .00 9 .0 234 70 .7
GF 1 0.05 93 5 1 .5
GF2 0.34 102 35 10 .6
GF3 1 .35 150 202 61 .0
Microsomal fr. (residual)II 20 .00 nd¶ nd¶
GF combined 1 .5 170 255 77 .0FIGURE 1 GF3. Chromatographic profiles of the products of the UDP-galactose :N-acetylglucosamine
galactosyltransferase. (a) assay in the absence of Triton X-100 :32 ftg protein, 169 nmol galactose trans-
ferred/mg protein/h ; (b) assay in the presence of 0.6% Triton X-100 :32 •g protein, 292 nmol galactose
transferred/mg protein/h. The arrows mark the unidentified radioactivity peak (see text) . In this, and in
all subsequent figures except Fig. 3 c and d, the position of the standards (left : N-acetyllactosamine, right:
galactose) is shown on the paper strip along the upper margin of the figure .
FIGURE 2 Chromatographic profiles of the products of the UDP-galactose :N-acetylglucosamine galac-
tosyltransferase. Assays carried out in the presence of 0.6% Triton X-100. (a) homogenate, 75 •g protein;
(b) total microsomal fraction, 50 •g protein.
transferred to N-acetyllactosamine by increasing
the amount of fraction protein (enzyme) added to
the assays led to extensive overlap of reaction
products and inability to separate N-acetyllactos-
amine (Fig. 3 a and b) from them. The only frac-
tion for which the reaction products appeared
reasonably well separated was GF I (Fig. 4) . This
difficulty was finally cleared by extracting the assay
mixture with a lipid solvent, i.e., chloroform : meth-
anol, 2 vol : I vol, at the end of the transfer reac-
tion on the assumption that the intermediate peak
is a glycolipid. The paper chromatograms of the
aqueous phases obtained in the extraction step
showed that the unknown peak was effectively re-
moved in the case of all fractions, while the mo-
bility of N-acetyllactosamine and galactose was
slightly increased . The results are illustrated for
homogenates and total microsomes in Fig . 3 c and
d and for GF 3 in Fig. 5 a and b. The nature of the
lipid soluble compound remains to be investigated
in future work.
The procedure thus modified was applied to all
relevant fractions and the results (Table VI) con-
firmed that in the case of ethanol-treated rats,
BERGERON, EHRENREICH, SIEKEVITZ, AND PALADE Golgi Fractions II. Biochemistry 81FIGURE 8 Chromatographic profiles of the products of the UDP-galactose :N-acetylglucosamine galac-
tosyltransf erase. Assays carried out in the presence of 0.6% Triton X-100. (a) homogenate, 375 µg protein,
whole assay mixture; (b) total microsomes, 250 µg protein, whole assay mixture; (c) homogenate, 375 µg
protein, aqueous phase of the assay mixture after extraction with chloroform-methanol, 3.18 nmol galac-
tose transferred/mg protein/h; (d) total microsomes, 250 µg protein, aqueous phase of the assay mixture
after extraction with chloroform-methanol, 19.2 nmol galactose transferred/mg protein/h . In Fig. 3 c and
d, the positions of the standards (left : N-acetyllactosamine, right : galactose) is indicated by the hori-
zontal bars along the upper margins of the graphs .
practically all the galactosyltransferase activity of
the parental microsomal fraction is recovered in
the set of three Golgi fractions. As in the first set of
experiments, the specific activity of the Golgi
fractions rises 50- to 80-fold above the activity of
the original homogenates.
To localize the transferase activity in further de-
tail, the VLDL content of Golgi elements was re-
moved by the procedure given in reference 2 and
the recovered Golgi membranes were assayed as
above. The results showed that the labeled lipid-
soluble product (arrow) separated with the mem-
branes (Fig. 6), not the VLDL, and that the spe-
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cific transferase activity increased twofold in the
case of GF, and GF2 (Table VII). No increase was
detected in GF3 membranes; this is in agreement
with our morphological findings which show that
there are relatively large amounts of removable
VLDLs in GF, and GF2 , but not in GF3 .
The activity of Golgi membranes remains sensi-
tive to Triton X-100 which increases it by -25%
(Table VII). This may reflect the partial reor-
ganization of Golgi membranes into closed vesicles
upon VLDL removal (2) or possibly a direct ac-
tivation of the enzyme over and above the effect ofFIGURE 4 GF,. Chromatographic profile of the
'products of the UDP-galactose :N-acetylglucosamine
galactosyltransferase reaction . Assay carried out in
the presence of 0.6% Triton X-100 with 50 µg protein.
155 nmol galactose transferred/mg protein/h .
removal of diffusion barriers by partial membrane
solubilization.
DISCUSSION
GF, , GF2 , and GF3 compare favorably in terms of
purity and recovery with the Golgi fractions or
Golgi-rich fractions already described in the litera-
ture.
Degree of Homogeneity
Since our morphologically cleanest fractions,
GF, and GF2 , have no detectable or very low
G6Pase and NADPH-cyt . c reductase activity, we
can conclude that the enzymes mentioned are
either absent from, or present in very low concen-
trations in, the membranes and content of the
Golgi elements recovered in our light and inter-
mediate fractions . On the basis of its G6Pase ac-
tivity, GF 3 , morphologically our least homogene-
ous fraction, is contaminated by ER-derived vesi-
cles to the extent of 15 % of its total protein . As-
sessed on the same basis, the degree of ER con-
tamination in the Golgi fractions or Golgi-rich
fractions described in the literature varies from
~ 8% (16) to --42% 8 (27). Cytochemical tests
carried out on our Golgi fractions indicate that
G6Pase reaction product is consistently absent
8 This is probably a maximal value since the figure
given for the G6Pase specific activity of smooth
microsomes is unusually low in this reference.
from recognizable Golgi elements and present
only in GF3 in small vesicles of the form and size
expected for smooth microsomes, i.e., vesicles de-
rived from the smooth ER (42). Accordingly, we
can conclude that Golgi elements in general, and
elements of vacuolar and cisternal type in particu-
lar, lack G6Pase activity and probably NADPH-
cyt. c-reductase and cyt . P-450. For the latter, our
findings confirm data already published by
Fleischer et al . (57) . This conclusion is in agree-
ment with earlier observations (21-23) on the ab-
sence of histochemically detectable G6Pase ac-
tivity in the Golgi complex of hepatocytes reacted
in situ, and on the lack of hypertrophy of the com-
plex during the drug-induced proliferation of the
hepatocytic ER. Conversely, our data confirm the
view that the enzymes mentioned are truly ER
membrane markers (cf. 36).
Recovery
Taken together, GFI , GF2 , and GF 3 account
for practically 10061o of the galactosyltransferase
activity present in our starting preparations, i.e.,
total microsomal fractions, which in turn account
for x-70% of the activity found in the original
homogenates. The recoveries reported in the lit-
erature are of -20% (16, 51) and range from less
than 10 % (16) to --40 % (52, 56) with a single ex-
ception (27) in which recoveries comparable to
ours (--90% of the activity of the microsomal frac-
tion and --70% of that of the homogenate) were
obtained, but at the price of -42 % ER contamina-
tion as assessed by G6Pase activity.
Our recovery data indicate that in the liver
galactosyltransferase is definitely a specific Golgi
activity in confirmation of the original proposal
advanced by Fleischer et al. (16) and repeated by
others (27, 52), and in agreement with earlier
radioautographic observations made on a variety
of cell types by Neutra and Leblond (58) and by
others (59) .
Effects of Ethanol Treatment
Our Golgi fractions were obtained from in the
livers of rats acutely intoxicated with ethanol . It is
known that under such conditions the lipid content
of the liver increases (60) and the Golgi elements
of the hepatocytes become overloaded with VLDL
particles (2) . It is also known that both changes are
reversible and that no other structurally detect-
able alterations are introduced by the intoxica-
tion, with the exception of an increase in the popu-
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83FIGURE 5 GF3. Chromatographic profiles of the products of the UDP-galactose:N-acetylglucosamine
galactosyltransferase reaction. Assays carried out with 50 µg protein in the presence of 0.6% Triton
X-100. (a) whole assay mixture; (b) aqueous phase of the assay mixture after extraction with chloroform-
methanol, 225 nmol galactose transferred/mg protein/h .
TABLE VI
UDP- Galactose : N-Ace tylglucosam ine Galactosyltransferase Activity in Cell Fractions Isolated from the Liver of
Ethanol- Treated Rats
Assay procedure used was Fleischer et al . (16) in the presence of 0 .6% Triton X-100 in the incubation
mixture, paper chromatography .
* Wet weight.
$ pmol galactose transferred/h/mg protein .
lation of large lipid droplets in the cytoplasmic
matrix of the hepatocytes (60, 2) . The data in
Tables IV and V show that the total and specific
activity of liver homogenates are comparable in
normal and ethanol-treated animals, but that re-
coveries and specific activities are substantially
lower in controls. These findings and those re-
ported in the companion paper (2), justify our
procedure since they show that the density per-
turbation introduced by VLDL overloading makes
possible the isolation of two nearly homogeneous
Golgi fractions (GF1 and GF2) and allows for satis-
factory recovery of Golgi elements (in GF, , GF2 ,
and GF3) as assessed by galactosyltransferase ac-
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tivity, without detectably affecting the activity o
the marker enzyme used . There are, however, re-
ports that longer or chronic treatment with ethanol
increases transferase activity (61) .
The literature on the eflects of ethanol on the
metabolism of lipids in the liver is profuse but still
inconclusive concerning mechanisms leading to
lipid and VLDL overloading (cf. 62, 63) . It is gen-
erally assumed that the rates of synthesis of fatty
acids (64) and triglycerides rise (65) as a result of
an increase in the NADH :NAD ratio in the cyto-
plasm (66), but a decrease in the rate of discharge
(67) and reduced utilization (68) may also be in-
volved.
Fraction
mg protein
Specific activity$ Total activity Recovery % g liver*
Homogenate 195 3 .2 624.0 100 .0
Microsomal fr. (initial) 21 19 399 .0 63 .9
GF I 0.05 155 7 .8 1 .2
GF2 0 .35 122 43 .0 6 .8
GF3 1 .30 255 331 .0 53 .10 061500
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FIGURE 6 Chromatographic profile of the products
of the UDP-galactose :N-acetylglucosamine galactosyl-
transferase. Assay carried out with 60 µg protein
without Triton X-100. The preparation used was a
membrane subfraction isolated from GF3. Area under
the N-acetyllactosamine peak corresponds to 164
nmol galactose transferred/mg protein/h . The arrow
marks the radioactive glycolipid peak.
TABLE VII
UDP-Galactose :N-Acetylglucosamine Galactosyl-
transferase Activity of Golgi Membranes
V
Specific
activity*
without Triton X-100 in the incubation mixture,
column chromatography.
§ Assay procedure used was Fleischer et al. (16),
paper chromatography.
Specificity of Golgi Membranes
Our data taken together with those already
available in the literature indicate that the en-
zymic activities of Golgi membranes are definitely
different from those of the membranes of the ER
which in the liver have been extensively investi-
gated by using smooth and rough microsomal frac-
tions. Hepatic Golgi membranes apparently lack
enzyme activities typical for hepatic ER mem-
branes, like G6Pase and the cyt. P-450 system.
The converse applies for galactosyltransferase ac-
tivity. Recent data indicate that the differences
are more extensive : hepatic Golgi fractions have
no detectable acyltransferase (Acyl-CoA : I , 2-di-
acyl-sn-glycerol acyltransferase) and cholinephos-
photransferase activity (69) and hence, lack the
capacity of synthesizing phosphatidylcholine and
triglycerides, which is known to be characteristic
for liver microsomes (70) . Conversely, there is sug-
gestive evidence obtained by both cell fractionation
(56) and autoradiography (71, 72) that other
transferase activities (fucosyl and sialyl trans-
ferases) are primarily associated with Golgi mem-
branes. The finding appears to apply for both
exogenous (56) and endogenous (73) acceptors of
the sugar transferred.
Data obtained on Golgi-rich fractions prepared
from liver by the procedure of Morrb et al . (53)
also indicate that the gross lipid composition of the
Golgi fractions is different from that of both micro-
somal and plasmalemmal fractions (74) and is
characterized by an intermediate content of
sphingomyelin and cholesterol . Similar data are
available for the Golgi membranes of the guinea
pig pancreas isolated, in this case, as a smooth
microsomal fraction (75).
It follows that Golgi membranes differ from ER
membranes in both enzymic activities and lipid
composition. They also appear to be different from
the plasmalemma although in this case the infor-
mation available is much more limited and less
relevant: it pertains to whole plasmalemmal frac-
tions when the preparation of interest should be
limited to that domain of the plasmalemma with
which membranes of Golgi origin interact during
secretory discharge.
The data presented and discussed in this paper
also indicate that the ER, Golgi, and plasma mem-
branes share some common activities. For instance,
AMPase is found in all three fractions but in
different degrees of concentration, and the cyt . b 5
chain is present at least in the ER and Golgi
membranes. 9 The true extent of the overlap (or
9 Our data indicate that the whole chain (NADH-
cyt. c-reductase and cyt. b5) is present in rat liver
Golgi fractions, but others have reported the presence
of the cyt. b5 (57) and the absence of the reductase
(51) in Golgi fractions or Golgi-rich fractions pre-
pared from the same source. Both enzymes have been
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Fraction
C
GFI$ 93 190
GF2$ 110 210
GF3$ 160 170
GF combined § + Triton X-100 230
GF combined § - Triton X-100 172
* nmol galactose transferred/h/mg protein.
$ Assay procedure used was Hassid-Babad (15)conversely of specificity) in these membranes is,
however, difficult to assess because many of their
components, especially their proteins, are still
unknown and because their resolution in gels is
still incomplete (cf. 76) and grossly affected by
the presence of the secretory proteins in the
content (77 and K . Howell, unpublished observa-
tions) .
A better understanding of the situation could be
obtained in the future by careful isolation of the
corresponding membranes (Golgi, ER) from their
content and by a better electrophoretic resolution
of the proteins of both subfractions. Here again
our procedure has an advantage over those al-
ready published : it provides means for the separa-
tion of Golgi membranes from the content of Golgi
elements. As already mentioned, the problem is
different for the plasmalemmal fractions . In their
case, the comparison with Golgi membranes should
be limited to functionally relevant domains of the
plasmalemma.
Functional Implications
Although the available evidence is still frag-
mentary, it becomes clear that severe restrictions
are imposed on the exchange of molecular com-
ponents between the ER and the Golgi membranes
and probably, but less certainly, between the Golgi
membrane and the plasmalemma . A priori, such
exchanges could take place when membranes es-
tablish continuity with one another during the
intracellular transport and discharge of secretory
proteins. The exact anatomy of the sites of con-
tinuity between the ER and the Golgi complex are
unknown in the hepatocyte. In the pancreatic
exocrine cell, it has been postulated that the trans-
port of the secretory product involves the small
vesicles at the periphery of the Golgi complex
which presumably act as shuttles between the
transitional elements of the rough ER and Golgi-
condensing vacuoles (78) . In the case of secretory
granules, it is sufficiently clear that transport to the
sites of discharge does not involve continuous chan-
nels and that the secretory granules discharge in-
termittently by fusion of their Golgi-derived mem-
branes with the plasmalemma (79). In both cases,
mechanisms seem to be at work to maintain in
constant relative proportions the volumes, or sur-
face areas, of the compartments involved in the
detected, however, in Golgi-rich fractions prepared
from beef liver (16, 57).
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overall process (80) . But the fate of the mem-
branes involved in these operations, especially the
fate of the secretory granule membranes after dis-
charge, is still a matter of debate. If the continuity
between ER and Golgi were permanent as postu-
lated by Morr6 et al. (81) and Claude (82), we
must conclude that diffusion in the plane of the
membrane for both lipids and proteins is severely
restricted from one membrane to the other, al-
though such diffusion is known to occur in other
systems (83, 84) on account of the fluidity of mem-
brane lipids. If the ER-Golgi continuity were in-
termittent and secretory products were moved
from one compartment to the next pari passu with
a membrane container, then we must postulate
that: (a) added membrane is removed from the re-
ceiving compartment to satisfy the constancy of
relative proportions under normal conditions of
operation, and (b) the removal is nonrandom in
character, i.e., the piece of membrane removed
from the receiving compartment is exactly the piece
of membrane that came from the donor compart-
ment. Without nonrandom removal there would
be complete mixing of membrane components,
lipids as well as proteins, which is contrary to ex-
perimental findings at least as far as the ER and
Golgi membranes are concerned.
Membrane movement and relocation have been
related in the past to the transport of secretory
products as well as to membrane biogenesis. The
first type of relation is a reasonably well-established
fact, at least in the case of the interaction between
secretion granule membranes and plasmalemma .
The second relation is still a postulate which pro-
poses that the ER membrane is the precursor of the
Golgi membrane which in turn is the precursor of
the plasmalemma, the membrane being modified
at the Golgi station before being removed to the
cell surface (cf. 85). At present, there is no direct
evidence for this postulate . It may well apply, but
the new findings indicate that extensive and com-
plex modifications, involving both subtraction and
addition of components, must occur at least at the
transition from ER to Golgi. Hence, alternative
mechanisms should be considered. For instance,
the membrane of each compartment may be as-
sembled in situ using at least in part previously
soluble components as in the case of mitochondrial
(86) or chloroplast membranes (87), or the mem-
brane container may bring forth from one com-
partment to the next in series not only secretory
proteins but also some proteins which are selec-
tively allowed to diffuse in the plane of the mem-brane of the receiving compartment while the
other components are retained in, and removed
with, the carrier.
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